1. Home
  2. VRAR vs PMN Comparison

VRAR vs PMN Comparison

Compare VRAR & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The Glimpse Group Inc.

VRAR

The Glimpse Group Inc.

HOLD

Current Price

$0.83

Market Cap

21.9M

Sector

Technology

ML Signal

HOLD

Logo ProMIS Neurosciences Inc. (ON)

PMN

ProMIS Neurosciences Inc. (ON)

HOLD

Current Price

$8.21

Market Cap

23.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VRAR
PMN
Founded
2016
2004
Country
United States
Canada
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Pharmaceuticals and Biotechnology
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
21.9M
23.5M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
VRAR
PMN
Price
$0.83
$8.21
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
3
Target Price
$2.62
$72.67
AVG Volume (30 Days)
123.6K
33.6K
Earning Date
02-12-2026
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$9,488,209.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$72.00
N/A
P/E Ratio
N/A
N/A
Revenue Growth
16.60
N/A
52 Week Low
$0.80
$6.27
52 Week High
$4.48
$39.75

Technical Indicators

Market Signals
Indicator
VRAR
PMN
Relative Strength Index (RSI) 30.57 70.11
Support Level $0.89 $8.31
Resistance Level $1.10 $9.15
Average True Range (ATR) 0.09 0.56
MACD -0.01 -0.22
Stochastic Oscillator 2.79 37.68

Price Performance

Historical Comparison
VRAR
PMN

About VRAR The Glimpse Group Inc.

The Glimpse Group Inc is a diversified immersive technology platform company, focused on providing enterprise solutions in virtual reality (VR), augmented reality (AR), and spatial computing. The company operates multiple subsidiaries that develop VR and AR software and services across various industries, including corporate training, education, healthcare, government, defense, marketing, retail, and financial services. It also offers AI-driven spatial computing platforms that support simulations, social VR, behavioral health, and corporate events. The Company reports its revenues in three categories: Software Services, Software License and Software-as-a-Service (SaaS), and Royalty Income, with the majority being from the Software Services category.

About PMN ProMIS Neurosciences Inc. (ON)

ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.

Share on Social Networks: